MoonLake Immunotherapeutics | Evaluate

Spotlight – following Humira in hidradenitis suppurativa

Immune agents old and new are trying to make a splash in what could turn into a billion-dollar market.

October 20, 2022

Bispecifics move beyond cancer

Hitting two targets with one molecule is all the rage in oncology, but Roche and others have taken this work into other disease areas.

February 25, 2022

Crunch time for the Spac space

This month has seen two blank-cheque company deals fall apart, and more terminations should be expected.